GENE ONLINE|News &
Opinion
Blog

Migraine
Neurolief’s Neuromodulation Device Receives Japanese Approval for At-Home Migraine Treatment
2024-01-16
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Daiichi Sankyo Partners with Lilly on a Second Migraine Drug Deal in Japan
2021-09-01
Spotlight: The Revitalization of Chronic Migraine Therapies
2020-09-02
Ubrelvy Approval, the Best New Year Gift for CGRP Migraine Victims
2020-01-09
Weekly Top 5 in China (0210-0216)
2019-02-18
Clash of three migraines medications & cost benefit for patients
2018-10-01
AJOVY™, Teva’s new migraine drug gets USFDA approval
2018-09-21
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top